about
The immune system's involvement in obesity-driven type 2 diabetesThe outliers become a stampede as immunometabolism reaches a tipping pointLymphocyte roles in metabolic dysfunction: of men and miceCellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistanceMechanisms of inflammatory responses in obese adipose tissue.Lipid antigens in immunity.Invariant natural killer T cells as sensors and managers of inflammation.The Response of CD1d-Restricted Invariant NKT Cells to Microbial Pathogens and Their ProductsActivation of natural killer T cells promotes M2 Macrophage polarization in adipose tissue and improves systemic glucose tolerance via interleukin-4 (IL-4)/STAT6 protein signaling axis in obesity.Activation of invariant natural killer T cells by lipid excess promotes tissue inflammation, insulin resistance, and hepatic steatosis in obese mice.Short term high fat diet challenge promotes alternative macrophage polarization in adipose tissue via natural killer T cells and interleukin-4.Natural killer T cells in adipose tissue prevent insulin resistanceMice subjected to aP2-Cre mediated ablation of microsomal triglyceride transfer protein are resistant to high fat diet induced obesityNatural killer and natural killer T cells in liver fibrosisIncreased susceptibility of natural killer T-cell-deficient mice to acetaminophen-induced liver injury.Contribution of lipid-reactive natural killer T cells to obesity-associated inflammation and insulin resistance.Hallmarks of Tissue-Resident Lymphocytes.Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production.Cutting edge: IL-25 elicits innate lymphoid type 2 and type II NKT cells that regulate obesity in mice.Mice lacking natural killer T cells are more susceptible to metabolic alterations following high fat diet feeding.UVB-induced skin inflammation and cutaneous tissue injury is dependent on the MHC class I-like protein, CD1dImmunological goings-on in visceral adipose tissue.Invariant natural killer T cells in adipose tissue: novel regulators of immune-mediated metabolic disease.Morphological and inflammatory changes in visceral adipose tissue during obesity.Adipose invariant natural killer T cells.Regulation of metabolism by the innate immune system.Unusual Suspects in the Development of Obesity-Induced Inflammation and Insulin Resistance: NK cells, iNKT cells, and ILCs.Exercise and caloric restriction alter the immune system of mice submitted to a high-fat diet.Communication between natural killer T cells and adipocytes in obesity.CD1d-mediated presentation of endogenous lipid antigens by adipocytes requires microsomal triglyceride transfer protein.The benefits of restraint: a pivotal role for IL-13 in hepatic glucose homeostasis.Role of NKT Cells in the Pathogenesis of NAFLD.Endogenous lipid antigens for invariant Natural Killer T cells hold the reins in adipose tissue homeostasis.Sevelamer Improves Steatohepatitis, Inhibits Liver and Intestinal Farnesoid X Receptor (FXR), and Reverses Innate Immune Dysregulation in a Mouse Model of Non-alcoholic Fatty Liver Disease.Adaptive Immunity and Metabolic Health: Harmony Becomes Dissonant in Obesity and Aging.CD1d-Restricted pathways in hepatocytes control local natural killer T cell homeostasis and hepatic inflammation.Deficiency of Invariant Natural Killer T Cells Does Not Protect Against Obesity but Exacerbates Atherosclerosis in Ldlr-/- Mice.Adipocyte CD1d determines adipose inflammation and insulin resistance in obesity.Low-Grade Inflammation, Obesity, and Diabetes.Role of Natural Killer T Cells in the Development of Obesity and Insulin Resistance: Insights From Recent Progress.
P2860
Q27001164-223849DE-3FF1-4679-A498-731B6DD89EABQ27005951-4BAB4748-54CA-439E-8788-B5E27A629829Q27687298-763798E4-DA79-4D8C-A5C1-D1C32EF8C0F8Q30009848-C31D34B7-89B8-45B1-8CA9-130717B8469DQ33699810-6EF25100-7308-4907-B63B-419256C53112Q34025822-F949E29B-0933-4684-8C47-26CA52D7B80AQ34302295-DEB86B64-CD32-4341-9CAE-E63A2F37E55AQ35600087-31C4AA3C-4E23-4D67-A2D8-D841CE79F82AQ35922180-8EA4FADE-5042-4C4B-BA9C-320266D05F40Q35982680-8EF18DC6-6961-444F-9601-C34099D24AECQ36097975-AA37E79D-88CF-4861-BFD9-6EA6BD058712Q36190718-90997408-27C2-4C9A-945A-836203271AD1Q36446306-660E9FF3-E628-46B7-A967-005730031676Q36553227-6161841A-06CE-4160-82B8-4F3FC8F52BA8Q36756077-54E26D37-EC99-4C51-BEAB-9502A2330C8BQ36866122-CE39059A-43DF-4C10-BDB6-7B5C9F875D03Q37152701-DD18151E-F4A1-440A-8FD0-D0D7F82AA2C0Q37191048-00A92109-9585-45BF-8967-9A79A56915CEQ37358129-C4851A3F-CCFA-44CB-98A1-219E1CA8895BQ37495662-4F5F424C-8FE8-4764-854C-CA449DE9CAEEQ37501797-B943E6E8-1B35-4140-84AE-2BCF89B88D36Q38112933-92D54CF7-A002-4642-9871-623FE4D0AAC2Q38120169-0DEBB145-72F5-4C2D-8F2B-1FEABAD38338Q38172822-A4063BAE-37A2-46BE-AF1E-D80CBF090612Q38199760-7A013CC5-1854-40CB-83E0-1B6C81365F5EQ38629225-7E272991-862B-456F-919F-1EE59C7873ABQ39325855-076616C9-9D02-4822-83EF-EC390BE9F3A6Q39376116-62A0D5BD-8432-41CE-9B33-6A0B4FDC362FQ41813424-275717C2-26D8-47D5-A7C2-91FD654A5941Q41857883-A962D7E4-B87E-4472-8D5F-B3A6FAF597BCQ41865644-7CA33537-E2AE-4FEE-AF7E-F6F859DAA2AFQ41873565-A8502AEA-99B0-4A8B-9457-6A41E39E49A4Q41998668-8A2B54CB-258E-4830-BE73-5BE3FCA3A418Q42725751-67A3E2D9-531B-47C3-9649-1AFE4B75DD49Q47670316-FB6D3287-E901-41DF-9DB1-35017B9A6616Q47820461-8E54A62B-B541-439F-96B9-0217D195E1B2Q50117639-4B71EEA1-9717-42BB-BD4A-EE56D5D1D0CAQ53080398-3A44D30D-1FFB-4EA9-8028-DCC77E1367FCQ53806699-3AB87787-AA39-4A86-8FB8-1D04B0D26536Q55365683-2F8760BC-CFB4-4EDA-A871-FD310055DACF
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Impact of CD1d deficiency on metabolism.
@ast
Impact of CD1d deficiency on metabolism.
@en
Impact of CD1d deficiency on metabolism.
@nl
type
label
Impact of CD1d deficiency on metabolism.
@ast
Impact of CD1d deficiency on metabolism.
@en
Impact of CD1d deficiency on metabolism.
@nl
prefLabel
Impact of CD1d deficiency on metabolism.
@ast
Impact of CD1d deficiency on metabolism.
@en
Impact of CD1d deficiency on metabolism.
@nl
P2093
P2860
P50
P1433
P1476
Impact of CD1d deficiency on metabolism
@en
P2093
Charles Annicelli
Hui-Young Lee
Maya E Kotas
P2860
P304
P356
10.1371/JOURNAL.PONE.0025478
P407
P577
2011-09-29T00:00:00Z